Circulating levels of visfatin, resistin and pro-inflammatory cytokine interleukin-8 in acute pancreatitis

Pancreatology

Volumn 10, Issue 4, 2010, Pages 477-482

  Daniel, Piotr ^a   Leśniowski, Bartosz ^a   Mokrowiecka, Anna ^a   Jasińska, Anna ^a   Pietruczuk, Mirosława ^a   Małecka Panas, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Acute pancreatitis; Interleukin 8; Pre B cell colony enhancing factor; Resistin; Visfatin

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ACUTE PANCREATITIS; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS;

EID: 77955603304     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000276986     Document Type: Article

References (36)

1. Mora S, Pessin JE: An adipocentric view of signaling and intracellular trafficking. Diabetes Metab Res Rev 2002; 18 : 345-356.
2. Beltowski J: Adiponectin and resistin-new hormones of white adipose tissue. Med Sci Monit 2003; 9:RA55-RA61.
3. Rabe K, Lehrke M, Parhofer KG, et al: Adi-pokines and insulin resistance. Mol Med 2008; 14:741-751.
4. Abu-Hilal M, Armstrong T: The impact of obesity on the course and outcome of acute pancreatitis. Obes Surg 2008; 18 : 326-328.
5. Sempere L, Martinez J, de Madaria E, et al: Obesity and fat distribution imply a greater systemic inf lammatory response and a worse prognosis in acute pancreatitis. Pancreatol-ogy 2008; 8:257-264.
6. Luk T, Malam Z, Marshal JC: Pre-B cell colony-enhancing factor (PBEF)/Visfatin: a novel mediator of innate immunity. J Leuk Biol 2008; 83:804-816.
7. B okarewa M, Na gaev I, D a hlberg L , e t a l: Re-sistin, an adipokine with potent proinflam-matory properties. J Immunol 2005; 174: 5789-5798.
8. Dahl TB, Yndestad A, Skjelland M, et al: Increased expression of visfatin in macro-phaghes of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007; 115:972-980.
9. Garcia JG: Searching for candidate genes in acute lung injury: SNPs, Chips and PBEF. Trans Am Clin Climatol Assoc 2005; 116: 205-219.
10. Liu P, Li H, Cepeda J, et al: Critical role of PBEF expression in pulmonary cell inflammation and permeability. Cell Biol Intern 2009; 33:19-30.
11. Moschen AR, Kaser A, Enrich B, et al: Visfa-tin, an adipocytokine with proinf lammatory and immunomodulating properties. J Im-mun 2007; 178:1748-1758.
12. Silswal N, Singh AK, Aruna B, et al: Human resistin stimulates the pro-inf lammatory cy-tokines TNF alpha and IL-12 in macro-phages by NFkappaB dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092-1101.
13. Ognjanovic S, Bao S, Yamamoto SY, et al: Ge-nomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001; 26: 107-117.
14. Hector J, Schwarzloh B, Goehring J, et al: TNF-alpha alters visfatin and adiponectin levels in human fat. Horm Metab Res 2007; 39:250-255.
15. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, et al: Resistin messenger-RNA expression is increased by proinflammatory cyto-kines in vitro. Biochem Biophys Res Com-mun 2003; 309:286-290.
16. Fasshauer M, Klein J, Neumann S, et al: Tumor necrosis factor a is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2001; 288:1027-1031.
17. Brentano F, Schorr O, Ospelt C, et al: Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arth Rheum 2007; 56: 2829-2839.
18. Kendal CE, Bryant-Greenwood GD: Pre-B-cell colony-enhancing factor (PBEF/Visfa-tin) gene expression is modulated by NF-kappaB and AP-1 in human amniotic epithelial cells. Placenta 2007; 28: 305-314.
19. Axelsson J, Witasp A, Carrero JJ, et al: Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis 2006; 48: 916-925.
20. Ye SQ, Simon BA, Maloney JP, et al: Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005; 171:361-370.
21. Konrad-Zerna A, Lehrke M, Schachinger V, et al: Resistin is an inflammatory marker of inflammatory bowel disease in human. Eur J Gastroenterol Hepatol 2007; 19: 1070-1074.
22. Lesniowski B, Kumor A, Daniel P, et al : Eval-uation of serum concentration of selected adipocytokines in acute pancreatitis. Gas-troenterol Pol 2007; 14 : 415-417.
23. Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 1997; 15: 675-705.
24. Mukaida N: Interleukin-8:an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000; 72: 391-398.
25. Mukaida N, Harada A, Yasumoto K, et al: Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8), and monocyte chemo-tactic and activating factor (MCAF). Micro-biol Immunol 1992; 36:773-789.
26. Fain JN, Madan AK, Hiler ML, et al: Comparison of the release of the adipokines by adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 2004; 145:2273-2282.
27. Middleton J, Neil S, Wintle J, et al: Trans-cytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997; 91:385-395.
28. Balthazar EJ: CT diagnosis and staging of acute pancreatitis. Radiol Clin North Am 1989; 27:19-37.
29. Schaffler A, Landfried K, Volk M, et al: Potential of adiopkines in predicting peripan-creatic necrosis and severity in acute pancreatitis: pilot study. J Gastroenterol Hepatology 2007; 22:326-334.
30. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, et al: Resistin messenger-RNA expression is increased by proinflammatory cyto-kines in vitro. Biochem Biophys Res Com-mun 2003; 309:286-290.
31. Lee JH, Ort T, Ma K, et al: Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro osteoarthritis cartilage 2009; 17: 613-620.
32. Samara A, Pfister M, Marie B, et al. Visfatin, low-gradeinflammation and body mass index (BMI). Clin Endocrinology 2008; 69: 568-574.
33. Matsui H, Tsutsumi A, Sugihara M, et al: Visfatin (pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67:571-572.
34. Frasshauer M, Waldeyer T, Seege J, et al: Serum levels of adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol-og y 2008; 69 : 69-73.
35. Chandru H, Boggaram V: The role of sphin-gosine 1-phosphate in the TNF-alpha induction of IL-8 gene expression in lung epithelial cel ls. Gene 2007; 391: 150-160.
36. Andoh A, Takaya H, Saotome T, et al: Cyto-kine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gas-troenterology 2000; 119: 211-219.